Afternoon session [Active stocks and traded stocks]

*Bio-Chemicals <4548> 776 +12 A phase 3 clinical trial for osteoarthritis treatment product 'Gel-One' has commenced in Japan. The resistance to further gains is significant. *Riken Technos <4220> 1025 +2625 The upward revision of the financial estimates for the fiscal year ending March 2025 and the announcement of a Share Buyback program of 3.8% of outstanding stocks. *SCSK <9719> 3776 +13 Domestic securities have upgraded their rating due to expected synergy effects from the integration. The resistance to further gains is significant. *GladCube <9561> 1168 -92 The global...

Fisco JapanFeb 25 02:10 ET

February 25 [Today's Investment Strategy]

[Fisco Selected Stocks]【Material Stocks】Escrow Agent Japan <6093> 160 yen (2/21) Engaged in real estate-related business such as escrow (third-party deposit), contract services, human resource dispatch, and auctions. While promoting the digital transformation of registration-related operations associated with real estate transactions, obtained a Business model patent for the cloud play in the progress management system, "EAJ Platform System (EPS)," and the business processes utilizing it.

Fisco JapanFeb 24 19:02 ET

Focus on biochemistry and Star Micronics HD, while V-Cube and high-pressure gas seem to be soft.

In the Tokyo market during the three-day weekend, on the 21st, the Dow Jones Industrial Average fell by $748.63, while yesterday, the 24th, it rose by $33.19 to $43,461.21. The Nasdaq Composite Index dropped by 438.36 points on the 21st and fell by 237.08 points yesterday to 19,286.93. Yesterday, the Chicago Nikkei 225 Futures were down 770 yen from Osaka daytime, at 38,020 yen. The exchange rate is 1 dollar = 149.60-70 yen. In today's Tokyo market, a special profit (subsidy income) of 5.09 is expected for the fourth quarter of the fiscal year ending February 2025.

Fisco JapanFeb 24 18:15 ET

Biochemistry --- A pharmaceutical company with strengths in "carbohydrate science" has obtained approval for hernia-related Pharmaceuticals from U.S. authorities, which will be a future catalyst.

Bikakukagaku Industry (4548) is a pharmaceutical company that has been established for over 70 years. Specializing in the scientific field of "Carbohydrate Science," which involves complex carbohydrates and sugar chains, the company has produced numerous Pharmaceuticals and Medical Devices. The distinctive feature of their Business model is that they narrow down their research and development targets and diseases, engaging in niche research and development activities that utilize their technology and know-how related to carbohydrate science. Additionally, the company does not have a pharmaceutical sales division and develops a Business model that forms sales partnerships with pharmaceutical companies that have strengths in various product areas.

Fisco JapanFeb 21 03:06 ET

MITSUBISHI ESTATE, 3Q operating profit increased by 32.5% to 194.4 billion yen.

MITSUBISHI ESTATE <8802> announced its financial results for the third quarter of the fiscal year ending March 2025, with operating revenue increasing by 13.1% year-on-year to 1 trillion 47.9 billion 19 million yen, and operating profit rising by 32.5% to 194.4 billion 78 million yen. Both income and capital gains are progressing smoothly towards the company's full-year financial estimates. In Japan, the stable Market Overview is being leveraged, leading to an increase in capital gains. Additionally, the Brokerage business is performing well. [Positive Evaluation] <8802> MITSUBISHI ESTATE Q4| <7740> TAMRON

Fisco JapanFeb 9 16:12 ET

Seikagaku: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)

JPXFeb 7 02:00 ET · Announcements

Daifuku construction, KFC, Duskin, and Shin Nihon Seiyaku (7th) (1332-5976)

※ The above Calendar is only a plan and may be subject to change due to company circumstances. --------------------------------------- February 7 (Friday) <1332> Nissui <1429> Aqua Japan <143A> Ishin <1450> Tanaka Construction Industry <151A> Dai <167A> Ryosan Ryoho <1717> Meihou Facility <1721> Comsys

Fisco JapanFeb 6 16:30 ET

List of conversion stocks (Part 1) [Parabolic Signal Conversion Stocks]

○List of stocks undergoing Buy conversion in the market Code Stock Name Closing Price SAR Tokyo Main Board <1301> Kiyokyo 4115 3945 <1332> Nissui 900873 <1377> Sakata Seed 34703370 <1726> Br. HD 346330 <1802> Obayashi Corporation 21012025 <1808> Haseko Corporation 20491980 <1820> Nishimatsu Construction 52485066 <1887> Japan National.

Fisco JapanDec 29, 2024 19:28 ET

Ferring Announces U.S. FDA Advisory Committee Meeting for SI-6603 (Condoliase), An Investigational Treatment in Lumbar Disc Herniation

BusinesswireDec 2, 2024 09:05 ET

List of stocks with cleared clouds (Part 2) [Ichimoku Kinko Hyo: List of Stocks with Cleared Clouds]

○List of Breakout Stocks in the Market Code Stock Name Closing Price Lead Span A Lead Span B Tokyo Main Board <1882> ToyoDoro 1237 1375.5 1239 <1968> Taihei Den50305341.255032.5<2127> Japan M&A658662.25722<2181> Persol HD243268.25244.5<2229> Calbee31393381.25

Fisco JapanNov 12, 2024 17:55 ET

Seikagaku: Confirmatory letter.

EDINETNov 12, 2024 00:58 ET · Announcements

Seikagaku: Half Year Report - Term 79 (2024/04/01 - 2025/03/31)

EDINETNov 12, 2024 00:56 ET · Announcements

Seikagaku Corp Sees FY Net Y3.45B

Dow JonesNov 10, 2024 23:00 ET

SoftBank, upward revision on 25/3, operating profit 950 billion yen ← 900 billion yen

SoftBank <9434> announced a revision to its financial estimates for the fiscal year ending in March 2025. The revenue has been upwardly revised from 6.2 trillion yen to 6.35 trillion yen, and the operating profit from 900 billion yen to 950 billion yen. The strong performance of its subsidiary, the leading smart phone payment provider PayPay, as well as the recovery of its mobile business, have contributed to this. [Positive evaluation] <9735> secom co midterm | <4521> Kaken Pharmaceutical midterm <7733> Olympus midterm | <8362> Fukui Bank revision <9005> Tokyu midterm | <4

Fisco JapanNov 10, 2024 16:33 ET

Seikagaku: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (consolidated)

JPXNov 8, 2024 02:00 ET · Announcements

Morinaga Milk, mcdonald's, Toyo Suisan, Eisai (8th) (1429-5463)

※Please note that the above calendar is tentative and subject to change based on the company's convenience. --------------------------------------- November 8th (Fri) <1429> Japan Aqua <1435> RoboHome <143A> Ishin <1450> Tanaka Construction Industry <1451> KHC <1518> Mitsui Matsushima HD <151A> Dai <167A> Ryo

Fisco JapanNov 7, 2024 16:30 ET

October 17th [Today's Investment Strategy]

[Fisco Selected Stock] [Material Stock] SIG Group <4386> 622 yen (10/16) Engaged in system development including DX support, operation of server/network equipment and software, maintenance, etc. Upwardly revised the financial estimates for the fiscal year ending March 2025. Operating profit is expected to be 30.6 million yen (67.2% increase from the previous year). This is raised by about 62% from the previous forecast. Orders are strong, and the subsidiary acquired at the end of the previous period is also performing well. Profit margin improvement has progressed, partially due to some expenses budget remaining unexecuted.

Fisco JapanOct 16, 2024 19:46 ET

Pay attention to biochemistry and SIG Group.

On the 16th in the US stock market yesterday, the dow jones industrial average closed at 43,077.70, up 337.28 points, while the nasdaq composite index rose 51.49 points to 18,367.08. In Chicago, the Nikkei 225 futures on the Osaka Exchange saw a 260 yen increase over the daytime session to 39,450 yen. The exchange rate was 1 dollar = 149.50-60 yen. In today's Tokyo market, Hamakyore <9037> announced a share buyback with a maximum of 0.27% of the issued shares and a buying commission, with a total revenue of September increasing by 11.9% from the previous month's 7.3%, expanding the growth rate.

Fisco JapanOct 16, 2024 19:15 ET

Seikagaku To Go Ex-Dividend On September 27th, 2024 With 15 JPY Dividend Per Share

September 26th (Japan Standard Time) - $Seikagaku(4548.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 15 JPY dividend per share. The

Moomoo NewsSep 25, 2024 21:00 ET

Ferring Presents Efficacy and Safety Data From Two Phase 3 Studies for Investigational Treatment, SI-6603 (Condoliase), in Lumbar Disc Herniation at NASS 2024

BusinesswireSep 25, 2024 08:00 ET